Literature DB >> 30411969

Cross-Subtype Detection of HIV-1 Capsid p24 Antigen Using a Sensitive Europium Nanoparticle Assay.

Mohan Kumar Haleyur Giri Setty1, Aditya Kurdekar1, Prerna Mahtani1, Jikun Liu1, Indira K Hewlett1.   

Abstract

Accurate and early detection of diverse HIV-1 subtypes using currently available p24 antigen assays have been a major challenge. We report the development of a sensitive time resolved fluorescence (TRF) europium nanoparticle immuno assay for cross subtype detection of p24 antigen using broadly cross-reactive antibodies. Several antibodies were tested for optimal reactivity with antigens of diverse HIV-1 subtypes and circulating recombinant forms. We tested HIV strains using this assay for sensitivity and quantification ability at the pico-gram per millilter level. We identified two broadly cross-reactive HIV-1 p24 antibodies C65690M and ANT-152, which detected all strains of HIV tested. These two antibodies also yielded a better signal to cutoff ratio for the same amount of antigen tested in comparison to a commercial assay. Using an appropriate combination of C65690M and ANT-152 p24 antibodies capable of detecting all HIV types and highly sensitive TRF-based europium nano particle assay platform, we developed a sensitive p24 antigen assay that can detect HIV infection of all HIV subtypes and may be useful in early detection.

Entities:  

Keywords:  CRFs; ELISA; HIV; europium nanoparticle assay; recombinants; time resolved fluorescence

Year:  2019        PMID: 30411969      PMCID: PMC6461306          DOI: 10.1089/AID.2018.0163

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  26 in total

1.  Low rates of p24 antigen detection using a fourth-generation point of care HIV test.

Authors:  Julie Fox; Helen Dunn; Siobhan O'Shea
Journal:  Sex Transm Infect       Date:  2010-11-17       Impact factor: 3.519

2.  Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?

Authors:  Thoai Duong Ly; Anne Ebel; Véronique Faucher; Valentine Fihman; Syria Laperche
Journal:  J Virol Methods       Date:  2007-03-28       Impact factor: 2.014

3.  Development of a microchip Europium nanoparticle immunoassay for sensitive point-of-care HIV detection.

Authors:  Jikun Liu; Bingchen Du; Panhe Zhang; Mohan Haleyurgirisetty; Jiangqin Zhao; Viswanath Ragupathy; Sherwin Lee; Don L DeVoe; Indira K Hewlett
Journal:  Biosens Bioelectron       Date:  2014-05-09       Impact factor: 10.618

4.  Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms.

Authors:  Mohan Kumar Haleyur Giri Setty; Jikun Liu; Prerna Mahtani; Panhe Zhang; Bingchen Du; Viswanath Ragupathy; Krishnakumar Devadas; Indira K Hewlett
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-15       Impact factor: 2.205

Review 5.  Fourth generation assays for HIV testing.

Authors:  Luca Vallefuoco; Claudia Mazzarella; Giuseppe Portella
Journal:  Expert Rev Mol Diagn       Date:  2016-05-06       Impact factor: 5.225

6.  Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra.

Authors:  Bernard Weber; Annemarie Berger; Holger Rabenau; Hans Wilhelm Doerr
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests.

Authors:  L L Jagodzinski; D L Wiggins; J L McManis; S Emery; J Overbaugh; M Robb; S Bodrug; N L Michael
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

8.  Evaluation of a rapid antigen and antibody combination test in acute HIV infection.

Authors:  Silvia Faraoni; Andrea Rocchetti; Franca Gotta; Tina Ruggiero; Giancarlo Orofino; Stefano Bonora; Valeria Ghisetti
Journal:  J Clin Virol       Date:  2013-02-04       Impact factor: 3.168

Review 9.  Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences.

Authors:  Tracy L Creek; Gayle G Sherman; John Nkengasong; Lydia Lu; Thomas Finkbeiner; Mary Glenn Fowler; Emilia Rivadeneira; Nathan Shaffer
Journal:  Am J Obstet Gynecol       Date:  2007-09       Impact factor: 8.661

10.  Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast.

Authors:  Silvina Masciotra; Wei Luo; Ae S Youngpairoj; M Susan Kennedy; Susan Wells; Krystin Ambrose; Patrick Sprinkle; S Michele Owen
Journal:  J Clin Virol       Date:  2013-08-02       Impact factor: 3.168

View more
  2 in total

1.  Biotin Interference in Point of Care HIV Immunoassay.

Authors:  Mohan Kumar Haleyur Giri Setty; Sherwin Lee; Julia Lathrop; Indira K Hewlett
Journal:  Biores Open Access       Date:  2020-11-24

2.  Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides.

Authors:  Kimia Kardani; Atieh Hashemi; Azam Bolhassani
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.